UDP-sugar substrates of HAS3 regulate its O-GlcNAcylation, intracellular traffic, extracellular shedding and correlate with melanoma progression

Cellular and Molecular Life Sciences

Volumn 73, Issue 16, 2016, Pages 3183-3204

  Deen, Ashik Jawahar ^a   Arasu, Uma Thanigai ^a   Pasonen Seppänen, Sanna ^a   Hassinen, Antti ^b   Takabe, Piia ^a   Wojciechowski, Sara ^a   Kärnä, Riikka ^a   Rilla, Kirsi ^a   Kellokumpu, Sakari ^b   Tammi, Raija ^a   Tammi, Markku ^a   Oikari, Sanna ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

4MU; Glucosamine; GNPDA; Mannose; OGT; UGDH

Indexed keywords

GFAT1 PROTEIN; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; HYALURONAN SYNTHASE 3; HYALURONIC ACID; SYNTHETASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE DIPHOSPHATE GLUCURONIC ACID; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE; GLUCURONOSYLTRANSFERASE; HAS1 PROTEIN, HUMAN; HAS3 PROTEIN, HUMAN; N ACETYLGLUCOSAMINE; URIDINE DIPHOSPHATE SUGAR;

ACYLATION; ARTICLE; CARBOHYDRATE METABOLISM; CARCINOGENESIS; CELL MEMBRANE; CELL TRANSPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; ENDOCYTOSIS; ENDOSOME; ENZYME SUBSTRATE; EXOSOME; EXTRACELLULAR SPACE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HYALURONAN SYNTHESIS; LYSOSOME; MELANOMA; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CHLOROCEBUS AETHIOPS; COS CELL LINE; DISEASE COURSE; METABOLISM; PATHOLOGY; PROTEIN TRANSPORT; SKIN; SKIN TUMOR; TUMOR CELL LINE;

ACETYLGLUCOSAMINE; ACYLATION; ANIMALS; CELL LINE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; DISEASE PROGRESSION; ENDOCYTOSIS; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; MELANOMA; PROTEIN TRANSPORT; SKIN; SKIN NEOPLASMS; URIDINE DIPHOSPHATE N-ACETYLGLUCOSAMINE; URIDINE DIPHOSPHATE SUGARS;

EID: 84958745959     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-016-2158-5     Document Type: Article

References (60)

1. Bakkers J, Kramer C, Pothof J, Quaedvlieg NE, Spaink HP, Hammerschmidt M (2004) Has2 is required upstream of Rac1 to govern dorsal migration of lateral cells during zebrafish gastrulation. Development 131:525–537
2. Banerjee PS, Ma J, Hart GW (2015) Diabetes-associated dysregulation of O-GlcNAcylation in rat cardiac mitochondria. Proc Natl Acad Sci USA 112:6050–6055
3. Beckham CJ, Olsen J, Yin PN, Wu CH, Ting HJ, Hagen FK, Scosyrev E, Messing EM, Lee YF (2014) Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression. J Urol 192:583–592
4. Bodevin-Authelet S, Kusche-Gullberg M, Pummill PE, DeAngelis PL, Lindahl U (2005) Biosynthesis of hyaluronan: direction of chain elongation. J Biol Chem 280:8813–8818
5. Buse MG (2006) Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab 290:E1–E8
6. Cayli A, Hirschmann F, Wirth M, Hauser H, Wagner R (1999) Cell lines with reduced UDP-N-acetylhexosamine pool in the presence of ammonium. Biotechnol Bioeng 65:192–200
7. Cole RN, Hart GW (1999) Glycosylation sites flank phosphorylation sites on synapsin I: O-linked N-acetylglucosamine residues are localized within domains mediating synapsin I interactions. J Neurochem 73:418–428
8. Deen AJ, Rilla K, Oikari S, Karna R, Bart G, Hayrinen J, Bathina AR, Ropponen A, Makkonen K, Tammi RH, Tammi MI (2014) Rab10-mediated endocytosis of the hyaluronan synthase HAS3 regulates hyaluronan synthesis and cell adhesion to collagen. J Biol Chem 289:8375–8389
9. Evanko SP, Potter-Perigo S, Bollyky PL, Nepom GT, Wight TN (2012) Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration. Matrix Biol 31:90–100
10. Geng F, Zhu W, Anderson RA, Leber B, Andrews DW (2012) Multiple post-translational modifications regulate E-cadherin transport during apoptosis. J Cell Sci 125:2615–2625
11. Hart GW, Housley MP, Slawson C (2007) Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446:1017–1022
12. Hascall VC, Wang A, Tammi M, Oikari S, Tammi R, Passi A, Vigetti D, Hanson RW, Hart GW (2014) The dynamic metabolism of hyaluronan regulates the cytosolic concentration of UDP-GlcNAc. Matrix Biol 35:14–17
13. Heldin P, Basu K, Olofsson B, Porsch H, Kozlova I, Kahata K (2013) Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer. J Biochem 154:395–408
14. Hiltunen EL, Anttila M, Kultti A, Ropponen K, Penttinen J, Yliskoski M, Kuronen AT, Juhola M, Tammi R, Tammi M, Kosma VM (2002) Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors. Cancer Res 62:6410–6413
15. Hubbard C, McNamara JT, Azumaya C, Patel MS, Zimmer J (2012) The hyaluronan synthase catalyzes the synthesis and membrane translocation of hyaluronan. J Mol Biol 418:21–31
16. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, Miyauchi S, Spicer AP, McDonald JA, Kimata K (1999) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274:25085–25092
17. Jiang D, Liang J, Noble PW (2011) Hyaluronan as an immune regulator in human diseases. Physiol Rev 91:221–264
18. Jokela T, Oikari S, Takabe P, Rilla K, Karna R, Tammi M, Tammi R (2015) Interleukin-1beta-induced reduction of CD44 Ser-325 phosphorylation in human epidermal keratinocytes promotes CD44 homomeric complexes, binding to ezrin, and extended, monocyte-adhesive hyaluronan coats. J Biol Chem 290:12379–12393
19. Jokela TA, Jauhiainen M, Auriola S, Kauhanen M, Tiihonen R, Tammi MI, Tammi RH (2008) Mannose inhibits hyaluronan synthesis by down-regulation of the cellular pool of UDP-N-acetylhexosamines. J Biol Chem 283:7666–7673
20. Jokela TA, Makkonen KM, Oikari S, Karna R, Koli E, Hart GW, Tammi RH, Carlberg C, Tammi MI (2011) Cellular content of UDP-N-acetylhexosamines controls hyaluronan synthase 2 expression and correlates with O-linked N-acetylglucosamine modification of transcription factors YY1 and SP1. J Biol Chem 286:33632–33640
21. Kakizaki I, Kojima K, Takagaki K, Endo M, Kannagi R, Ito M, Maruo Y, Sato H, Yasuda T, Mita S, Kimata K, Itano N (2004) A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone. J Biol Chem 279:33281–33289
22. Karjalainen JM, Tammi RH, Tammi MI, Eskelinen MJ, Agren UM, Parkkinen JJ, Alhava EM, Kosma VM (2000) Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. Am J Pathol 157:957–965
23. Kultti A, Pasonen-Seppanen S, Jauhiainen M, Rilla KJ, Karna R, Pyoria E, Tammi RH, Tammi MI (2009) 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Exp Cell Res 315:1914–1923
24. Kultti A, Zhao C, Singha NC, Zimmerman S, Osgood RJ, Symons R, Jiang P, Li X, Thompson CB, Infante JR, Jacobetz MA, Tuveson DA, Frost GI, Shepard HM, Huang Z (2014) Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironment. Biomed Res Int 2014:817613
25. Manderson AP, Kay JG, Hammond LA, Brown DL, Stow JL (2007) Subcompartments of the macrophage recycling endosome direct the differential secretion of IL-6 and TNFalpha. J Cell Biol 178:57–69
26. Misra S, Hascall VC, Markwald RR, Ghatak S (2015) Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer. Front Immunol 6:201
27. Murray RZ, Kay JG, Sangermani DG, Stow JL (2005) A role for the phagosome in cytokine secretion. Science 310:1492–1495
28. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Matsumoto K (1995) Expression of local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun 215:483–488
29. Nykopp TK, Rilla K, Sironen R, Tammi MI, Tammi RH, Hamalainen K, Heikkinen AM, Komulainen M, Kosma VM, Anttila M (2009) Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content. BMC Cancer 9:143
30. Nykopp TK, Rilla K, Tammi MI, Tammi RH, Sironen R, Hamalainen K, Kosma VM, Heinonen S, Anttila M (2010) Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma. BMC Cancer 10:512
31. Oikari S, Venalainen T, Tammi M (2014) Borate-aided anion exchange high-performance liquid chromatography of uridine diphosphate-sugars in brain, heart, adipose and liver tissues. J Chromatogr A 1323:82–86
32. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, Garcia-Santos G, Ghajar C, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, Yuan J, Martins VR, Skog J, Kaplan RN, Brady MS et al (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18:883–891
33. Rilla K, Oikari S, Jokela TA, Hyttinen JM, Karna R, Tammi RH, Tammi MI (2013) Hyaluronan synthase 1 (HAS1) requires higher cellular UDP-GlcNAc concentration than HAS2 and HAS3. J Biol Chem 288:5973–5983
34. Rilla K, Pasonen-Seppanen S, Deen AJ, Koistinen VV, Wojciechowski S, Oikari S, Karna R, Bart G, Torronen K, Tammi RH, Tammi MI (2013) Hyaluronan production enhances shedding of plasma membrane-derived microvesicles. Exp Cell Res 319:2006–2018
35. Rilla K, Pasonen-Seppanen S, Karna R, Karjalainen HM, Torronen K, Koistinen V, Tammi MI, Tammi RH, Teravainen T, Manninen A (2012) HAS3-induced accumulation of hyaluronan in 3D MDCK cultures results in mitotic spindle misorientation and disturbed organization of epithelium. Histochem Cell Biol 137:153–164
36. Rilla K, Siiskonen H, Spicer AP, Hyttinen JM, Tammi MI, Tammi RH (2005) Plasma membrane residence of hyaluronan synthase is coupled to its enzymatic activity. J Biol Chem 280:31890–31897
37. Russell DL, Salustri A (2006) Extracellular matrix of the cumulus-oocyte complex. Semin Reprod Med 24:217–227
38. Schmaus A, Klusmeier S, Rothley M, Dimmler A, Sipos B, Faller G, Thiele W, Allgayer H, Hohenberger P, Post S, Sleeman JP (2014) Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasis. Br J Cancer 111:559–567
39. Siiskonen H, Poukka M, Tyynela-Korhonen K, Sironen R, Pasonen-Seppanen S (2013) Inverse expression of hyaluronidase 2 and hyaluronan synthases 1-3 is associated with reduced hyaluronan content in malignant cutaneous melanoma. BMC Cancer 13:181
40. Singleton PA (2014) Hyaluronan regulation of endothelial barrier function in cancer. Adv Cancer Res 123:191–209
41. Sironen RK, Tammi M, Tammi R, Auvinen PK, Anttila M, Kosma VM (2011) Hyaluronan in human malignancies. Exp Cell Res 317:383–391
42. Stern R (2008) Hyaluronan in cancer biology. Semin Cancer Biol 18:237
43. Stern R (2005) Hyaluronan metabolism: a major paradox in cancer biology. Pathol Biol (Paris) 53:372–382
44. Sun J, Lu F, He H, Shen J, Messina J, Mathew R, Wang D, Sarnaik AA, Chang WC, Kim M, Cheng H, Yang S (2014) STIM1- and Orai1-mediated Ca(2+) oscillation orchestrates invadopodium formation and melanoma invasion. J Cell Biol 207:535–548
45. Takabe P, Bart G, Ropponen A, Rilla K, Tammi M, Tammi R, Pasonen-Seppänen S (2015) Hyaluronan synthase 3 (HAS3) overexpression downregulates MV3 melanoma cell proliferation, migration and adhesion. Exp Cell Res 337:1–15. doi:10.1016/j.yexcr.2015.07.026
46. Tammi RH, Kultti A, Kosma VM, Pirinen R, Auvinen P, Tammi MI (2008) Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Semin Cancer Biol 18:288–295
47. Tammi RH, Passi AG, Rilla K, Karousou E, Vigetti D, Makkonen K, Tammi MI (2011) Transcriptional and post-translational regulation of hyaluronan synthesis. FEBS J 278:1419–1428
48. Tian X, Azpurua J, Hine C, Vaidya A, Myakishev-Rempel M, Ablaeva J, Mao Z, Nevo E, Gorbunova V, Seluanov A (2013) High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature 499:346–349
49. Toole BP (2009) Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities. Clin Cancer Res 15:7462–7468
50. Toole BP (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4:528–539
51. Toole BP, Slomiany MG (2008) Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol 18:244–250
52. Twarock S, Tammi MI, Savani RC, Fischer JW (2010) Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells. J Biol Chem 285:23276–23284
53. Vigetti D, Deleonibus S, Moretto P, Bowen T, Fischer JW, Grandoch M, Oberhuber A, Love DC, Hanover JA, Cinquetti R, Karousou E, Viola M, D’Angelo ML, Hascall VC, De Luca G, Passi A (2014) Natural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via protein O-GlcNAcylation. J Biol Chem 289:28816–28826
54. Vigetti D, Deleonibus S, Moretto P, Karousou E, Viola M, Bartolini B, Hascall VC, Tammi M, De Luca G, Passi A (2012) Role of UDP-N-acetylglucosamine (GlcNAc) and O-GlcNAcylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis. J Biol Chem 287:35544–35555
55. Vigetti D, Rizzi M, Moretto P, Deleonibus S, Dreyfuss JM, Karousou E, Viola M, Clerici M, Hascall VC, Ramoni MF, De Luca G, Passi A (2011) Glycosaminoglycans and glucose prevent apoptosis in 4-methylumbelliferone-treated human aortic smooth muscle cells. J Biol Chem 286:34497–34503
56. Warburg O, Posener K, Negelein E (1924) Über den Stoffwechsel der Carcinomzelle. Biochem Z 152:309–344
57. Weigel PH, DeAngelis PL (2007) Hyaluronan synthases: a decade-plus of novel glycosyltransferases. J Biol Chem 282:36777–36781
58. Wu M, Cao M, He Y, Liu Y, Yang C, Du Y, Wang W, Gao F (2015) A novel role of low molecular weight hyaluronan in breast cancer metastasis. FASEB J 29:1290–1298
59. Yang L, Wu XH, Wang D, Luo CL, Chen LX (2013) Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro. Mol Med Rep 8:1272–1278
60. Zhu W, Leber B, Andrews DW (2001) Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis. EMBO J 20:5999–6007